Neal-Beliveau BS[au] - Search Results

Year	Number of Results
1993	3
1995	1
1996	1
1997	1
1998	2
1999	1
2005	1
2015	1
2016	2
2018	1
2019	1
2022	0

1

Caenorhabditis elegans as a Model to Study the Molecular and Genetic Mechanisms of Drug Addiction.

Engleman EA, Katner SN, Neal-Beliveau BS. Engleman EA, et al. Among authors: neal beliveau bs. Prog Mol Biol Transl Sci. 2016;137:229-52. doi: 10.1016/bs.pmbts.2015.10.019. Epub 2015 Nov 24. Prog Mol Biol Transl Sci. 2016. PMID: 26810004 Free PMC article. Review.

2

Caenorhabditis elegans as a model system to identify therapeutics for alcohol use disorders.

Katner SN, Bredhold KE, Steagall KB 2nd, Bell RL, Neal-Beliveau BS, Cheong MC, Engleman EA. Katner SN, et al. Among authors: neal beliveau bs. Behav Brain Res. 2019 Jun 3;365:7-16. doi: 10.1016/j.bbr.2019.02.015. Epub 2019 Feb 22. Behav Brain Res. 2019. PMID: 30802531 Free PMC article.

3

Caenorhabditis elegans Show Preference for Stimulants and Potential as a Model Organism for Medications Screening.

Engleman EA, Steagall KB 2nd, Bredhold KE, Breach M, Kline HL, Bell RL, Katner SN, Neal-Beliveau BS. Engleman EA, et al. Among authors: neal beliveau bs. Front Physiol. 2018 Aug 30;9:1200. doi: 10.3389/fphys.2018.01200. eCollection 2018. Front Physiol. 2018. PMID: 30214414 Free PMC article.

4

Functional and molecular differentiation of the dopamine system induced by neonatal denervation.

Joyce JN, Frohna PA, Neal-Beliveau BS. Joyce JN, et al. Among authors: neal beliveau bs. Neurosci Biobehav Rev. 1996 Autumn;20(3):453-86. doi: 10.1016/0149-7634(95)00025-9. Neurosci Biobehav Rev. 1996. PMID: 8880735 Free article. Review.

5

Serotonergic involvement in haloperidol-induced catalepsy.

Neal-Beliveau BS, Joyce JN, Lucki I. Neal-Beliveau BS, et al. J Pharmacol Exp Ther. 1993 Apr;265(1):207-17. J Pharmacol Exp Ther. 1993. PMID: 8386235

6

Embryonic Methamphetamine Exposure Inhibits Methamphetamine Cue Conditioning and Reduces Dopamine Concentrations in Adult N2 Caenorhabditis elegans.

Katner SN, Neal-Beliveau BS, Engleman EA. Katner SN, et al. Among authors: neal beliveau bs. Dev Neurosci. 2016;38(2):139-49. doi: 10.1159/000445761. Epub 2016 May 28. Dev Neurosci. 2016. PMID: 27233671 Free PMC article.

7

Asymmetrical changes of dopamine receptors in the striatum after unilateral dopamine depletion.

Xu ZC, Ling G, Sahr RN, Neal-Beliveau BS. Xu ZC, et al. Among authors: neal beliveau bs. Brain Res. 2005 Mar 21;1038(2):163-70. doi: 10.1016/j.brainres.2005.01.033. Brain Res. 2005. PMID: 15757632

8

Delayed plasticity of the mesolimbic dopamine system following neonatal 6-OHDA lesions.

Frohna PA, Neal-Beliveau BS, Joyce JN. Frohna PA, et al. Among authors: neal beliveau bs. Synapse. 1997 Mar;25(3):293-305. doi: 10.1002/(SICI)1098-2396(199703)25:3<293::AID-SYN9>3.0.CO;2-6. Synapse. 1997. PMID: 9068128

9

Timing: A critical determinant of the functional consequences of neonatal 6-OHDA lesions.

Neal-Beliveau BS, Joyce JN. Neal-Beliveau BS, et al. Neurotoxicol Teratol. 1999 Mar-Apr;21(2):129-40. doi: 10.1016/s0892-0362(98)00044-0. Neurotoxicol Teratol. 1999. PMID: 10192273

10

Behavioral responsitivity to dopamine receptor agonists after extensive striatal dopamine lesions during development.

Neal-Beliveau BS, Joyce JN. Neal-Beliveau BS, et al. Dev Psychobiol. 1998 May;32(4):313-26. Dev Psychobiol. 1998. PMID: 9589220

Save citations to file

Email citations

Send citations to clipboard

Add to Collections

Add to My Bibliography

Create a file for external citation management software

Your saved search

Your RSS Feed

Search Page

Search Results